Which antibiotic protects stem cell patients best? new study pits cipro against levo
NCT ID NCT03850379
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at 308 adults getting a stem cell transplant for blood cancer. Researchers compared two antibiotics, ciprofloxacin and levofloxacin, to see which one better prevents bacterial infections after transplant. The goal is to find the best option to keep patients safe during recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
antibiotics (ciprofloxacin and levofloxacin)
What this could lead to
If one antibiotic works better, it could reduce infections and improve recovery for stem cell transplant patients.
What could go wrong
This is a small, completed Phase 2 study, so results may not apply to all patients. Both drugs have known side effects like tendon issues or heart rhythm changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STEM CELL TRANSPLANT COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Henry Ford
Detroit, Michigan, 48202, United States